University of Lahore Teaching Hospital
Lahore, Punjab Province, 55150, Pakistan
NCT Number: NCT06031207
The study will employ a Cross-Sectional Validation Study design. The study will be conducted at the Department of Physical Therapy, University of Lahore Teaching Hospital, located on Defence Road, Lahore.
The anticipated duration of the study will be 09 months, commencing after the approval of the synopsis.
The sample size will be determined following the Kline Method, resulting in a total of 90 participants.
A Purposive Sampling Technique will be utilized to select the study participants.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lahore, Punjab Province, 55150, Pakistan
Study Type: Cross-Sectional Validation Study Location: Department of Physical Therapy, University of Lahore Teaching Hospital, Defence Road, Lahore Duration: 06 months (post-synopsis approval) Sample Size: 90 participants Sampling Technique: Purposive Sampling Consent and Ethics: Participants will provide written informed consent. Ethics approval will be obtained from the University of Lahore Ethics Committee.
Translation of FSS:
The Fatigue Severity Scale (FSS) will be translated into Urdu for data collection.
Two independent bilingual translators will create reports on translation difficulties and rationale.
These reports will inform a consensus meeting to develop a unified Urdu version, with comments documented.
The unified version will be backtranslated into English by native English-speaking translators unaware of the questionnaire's concept.
Expert Committee:
An expert committee comprising physical therapists, linguists, and a methodologist will review both language versions.
The goal is to ensure semantic, idiomatic, experiential, and conceptual equivalence and reach consensus on the final Urdu version of the FSS.
Patient Involvement:
The final Urdu FSS version will be administered to 20 fibromyalgia patients. These patients will also be interviewed to assess their understanding of questionnaire items.
Participants will receive additional information about fibromyalgia to prevent confusion.
Data Collection:
Data will be collected from 100 fibromyalgia patients using the final Urdu FSS version.
A retest will be conducted after 48 hours.
Additional Assessment:
All 90 participants will complete the Multidimensional Fatigue Inventory (MFI).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
The Fatigue Severity Scale (FSS) is a self-reported measure of fatigue and sleep disturbance in patients with fibromyalgia. It is a 9-item scale that assesses the severity of fatigue, the impact of fatigue on daily activities, and the degree of sleep disturbance. The FSS is a widely used instrument in research and clinical practice, and has been found to be a valid and reliable measure of fatigue and sleep disturbance in patients with fibromyalgia. The FSS items are rated on a 5-point Likert scale, with responses ranging from "not at all" to "extremely." The total score ranges from 0 to 36, with higher scores indicating greater levels of fatigue and sleep disturbance.
Time frame: 1 week
The Multidimensional Fatigue Inventory (MFI) is a self-report questionnaire designed to assess various dimensions of fatigue experienced by individuals. It is commonly used in research and clinical settings to measure and understand fatigue in different contexts. Respondents answer a series of questions related to each dimension on a Likert-type scale, typically ranging from 1 to 5 or 0 to 4. The scores from each dimension are summed to obtain subscale scores, and a total score is often calculated by summing all subscale scores. Higher scores indicate greater levels of fatigue.
University of Lahore
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05998369
Abdominal Pain, Autonomic Nervous System Diseases
Palo Alto, California, United States
View Trial DetailsNCT06752590
Fibromyalgia, Muscular Diseases
Nagakute, Aichi-ken, Japan
View Trial DetailsNCT05237050
Chronic Pain, Fibromyalgia
Gap, Hautes Alpes, France
View Trial DetailsNCT07665411
Fibromyalgia, Muscular Diseases
Covilha, Castelo Branco District, Portugal
View Trial Details